|
Liver Cancer Specialist in Dubai

Liver Cancer Specialist in Dubai

Liver cancer treatment decisions hinge on a question that is easy to overlook: is this cancer that started in the liver itself, or cancer that has spread there from somewhere else in the body? The two are managed very differently, and getting that distinction, along with an honest assessment of how well the rest of the liver is functioning, right at the start is essential for choosing the most appropriate treatment approach.

Chat on WhatsApp Call Now

Get Consultation

Fill out the form and our team will contact you shortly.

Liver Cancer Specialist in Dubai - Dr. Ajeet Tiwari

Liver Cancer Specialist in Dubai - Dr. Ajeet Tiwari

Liver cancer treatment decisions hinge on a question that is easy to overlook: is this cancer that started in the liver itself, or cancer that has spread there from somewhere else in the body? The two are managed very differently, and getting that distinction, along with an honest assessment of how well the rest of the liver is functioning, right at the start shapes every decision that follows for patients in Dubai weighing their options.

Dr. Ajeet Tiwari is an MCh surgical oncologist who reviews liver cancer cases for patients in Dubai, assesses whether surgery is realistic given the tumor's location and the liver's remaining function, and sets out a clear treatment plan once imaging and blood work are complete.

Book a Consultation

This page explains how that clinical assessment works and the criteria used to determine whether surgery is possible.

Primary Liver Cancer vs Cancer That Has Spread to the Liver

Hepatocellular carcinoma (HCC), the most common primary liver cancer, starts in the liver tissue itself and is frequently linked to underlying liver conditions such as hepatitis B, hepatitis C, or cirrhosis. Liver metastases, by contrast, are secondary cancer cells that have spread to the liver from another organ—most commonly colorectal cancer—and are managed as part of that primary cancer’s overall multidisciplinary protocol.

Why This Distinction Changes the Treatment Plan

Primary liver cancer surgery must balance tumor removal with preserving adequate functional liver volume, particularly when underlying cirrhosis is present. In metastatic disease, surgical decisions are coordinated closely with systemic therapy for the primary site, often incorporating chemotherapy before and after resection.

Liver Cancer Specialist in Dubai: Assessing Whether Surgery Is Possible

Before recommending surgical resection, a rigorous evaluation focuses on three key factors: tumor anatomical location relative to major vascular structures, the calculated future liver remnant (FLR), and baseline liver functional reserve—commonly quantified using the Child-Pugh scoring system.

Factor Assessed Why It Matters
Tumor size and location Determines whether surgical removal is technically feasible without compromising major inflow and outflow blood vessels
Future liver remnant (FLR) The volume and quality of healthy liver left after surgery must be sufficient to maintain post-operative metabolic function and prevent liver failure
Liver function (Child-Pugh score) Patients with compromised liver function or advanced cirrhosis may face unacceptable risks with major hepatic resection
Number of tumors Multifocal tumors across multiple lobes often favor systemic or targeted ablation approaches over extensive resection

Surgical and Non-Surgical Treatment Options

When resection is clinically feasible, a partial hepatectomy (liver resection) removes the tumor with a clear margin of healthy tissue via open or minimally invasive laparoscopic surgery. For smaller lesions or patients whose liver reserve limits surgical safety, local thermal destruction techniques offer effective alternatives.

Approach Best Suited For
Liver resection (surgery) Solitary or localized tumors that can be cleared with negative margins while leaving adequate functional liver remnant
Radiofrequency or microwave ablation Smaller tumors, or patients in whom major resection carries higher risk due to compromised background liver function
Combined approach Complex cases utilizing surgical resection for dominant lesions alongside targeted ablation for smaller, secondary lesions

Chemotherapy for Liver Cancer

For liver metastases originating from other organs, chemotherapy forms an integral part of the treatment pathway—frequently administered prior to resection to downsize tumors and test tumor biology, and continued post-operatively. In primary liver cancer (HCC), treatment depends more heavily on targeted systemic therapies, immunotherapy, and hepatic functional reserve than conventional cytotoxic regimens.

Liver Cancer Treatment Cost for Dubai Patients

Cost varies based on whether surgical resection, thermal ablation, or a combined multimodal procedure is selected, alongside systemic therapy requirements and length of inpatient monitoring. A clear, itemized cost estimate is provided following detailed radiological and laboratory review.

Liver Cancer Treatment for Patients in Riyadh, Jeddah and Kuwait

The second opinion service is available to patients evaluating liver and hepatobiliary cancer care from Riyadh, Jeddah, and Kuwait. Triphasic CT scans, liver MRI protocols, and hepatic function panels completed locally can be submitted for review, followed by a detailed video consultation.

How to Get Your Case Reviewed

Upload your contrast-enhanced CT/MRI scans, liver function tests (LFTs), and biopsy pathology reports through our second opinion portal. You will receive an oncologist evaluation followed by a scheduled video discussion outlining surgical operability and alternative localized strategies.

Find Out If Surgery Is Right for You

If you have imaging or liver function tests and want an honest assessment of whether surgery is realistic for your case, send them through the online second opinion page before deciding anything.

Request Case Review

Frequently Asked Questions

Find answers to common questions about liver cancer surgery, liver resection, ablation techniques, cirrhosis considerations, and international second opinions.

It depends on how advanced the cirrhosis is and how much healthy liver volume would remain after surgery, assessed primarily through the Child-Pugh score and vascular imaging. Some patients with well-compensated cirrhosis are suitable surgical candidates, while others achieve safer outcomes through thermal ablation or non-surgical therapies.

Resection surgically removes the tumor alongside a margin of healthy tissue. Ablation destroys cancer cells in situ using radiofrequency or microwave thermal energy delivered via a needle probe without removing liver parenchyma. The approach is determined by tumor size, location, and residual liver function.

The initial clinical review and consultation take place via structured video call so you understand whether surgery is realistic before making travel commitments. If surgical or procedural care is indicated, management takes place at Dr. Tiwari's hospital, with full logistics planned in advance.

No. Liver metastases are managed as part of the primary organ's cancer protocol, often in conjunction with systemic chemotherapy. Primary liver cancer management depends predominantly on baseline liver functional reserve, cirrhosis severity, and local tumor anatomy.

Cost depends on whether surgical resection, percutaneous/laparoscopic ablation, or a combination procedure is recommended, alongside systemic therapy and intensive care stay requirements. A transparent estimate is provided once imaging and functional tests are evaluated.

Yes, remote diagnostic review, surgical candidacy assessment, and video consultations are available to patients contacting us from Riyadh, Jeddah, Kuwait, and across the GCC region.